Placebo
Placebo is a pharmaceutical drug with 41,034 clinical trials. Currently 4,744 active trials ongoing. Historical success rate of 87.4%.
Success Metrics
Based on 26,380 completed trials
Phase Distribution
Phase Distribution
8584
Early Stage
12719
Mid Stage
12908
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.7%
26380 of 31536 finished
16.3%
5156 ended early
4744
trials recruiting
41,034
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
ACP-204 in Adults With Alzheimer's Disease Psychosis
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
Clinical Trials (41,034)
A Study to Evaluate ALN-HTT02 in Adult Patients With Huntington's Disease
A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
ACP-204 in Adults With Alzheimer's Disease Psychosis
Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain
A Study to Evaluate ALN-4285 in Adult Healthy Volunteers
Randomized Double-Blind Placebo-Controlled Adaptive Design Trial Of Intrathecally Administered Autologous Mesenchymal Stem Cells In Multiple System Atrophy
Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers
REALITY MONITORING AND DOPAMINE
Beeline: A Phase 3 Study in GRIN-related Neurodevelopmental Disorder
Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.
A Study to Assess the Safety, Tolerability, PK and PD of WIN378 in Participants With Moderate - Severe COPD
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection
Evaluation of the Novel Therapeutic Hepatitis B Virus Synthetic Long Peptide Vaccination ISA104
A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 41,034